About: Silexion Therapeutics Corp operates as a clinical-stage oncology-focused biotechnology company. It engages in the development of treatments for unsatisfactorily treated solid tumor cancers. The company is advancing its lead product candidate, SIL204, a small interfering RNA (siRNA) through Phase 2/3 clinical evaluation. It focuses on therapeutic advancements in the field of oncology, as well as developing its lead product candidate for pancreatic cancer. The company was founded in 2008 and is headquartered in Ramat Gan, Israel.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.50 (+4.17%)
SLXN NASDAQ Silexion Therapeutics Corp
Silexion Therapeutics Corp share price
SLXN price activity
Last Price
$1.500
Change (24hr)
0.06 USD (4.17%)
Volume
49.80K
Volume (4w avg)
-
Open
$1.46
Day Range
$1.26 - $1.61
Previous Close
$1.44
Last Trade
19 Nov, 9:00 pm GMT+0
Delayed
19 Nov, 9:00 pm GMT+0
SLXN price performance
Delayed
19 Nov, 9:00 pm GMT+0
SLXN details
SLXN Market Signals